Cargando…
Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
SUMMARY: Romosozumab is an effective treatment for spine osteoporosis because it reduces the incidence of new fractures and significantly increases the percent change in the spine BMD at 12 months. The percent change in the spine BMD is higher in patients not previously treated with other anti-osteo...
Autores principales: | Tominaga, A., Wada, K., Okazaki, K., Nishi, H., Terayama, Y., Kato, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996128/ https://www.ncbi.nlm.nih.gov/pubmed/33770201 http://dx.doi.org/10.1007/s00198-021-05925-3 |
Ejemplares similares
-
Romosozumab for osteoporosis
Publicado: (2021) -
Romosozumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2018) -
Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
por: Lim, Sian Yik
Publicado: (2022) -
Romosozumab in osteoporosis: yesterday, today and tomorrow
por: Wu, Dong, et al.
Publicado: (2023) -
Profile of romosozumab and its potential in the management of osteoporosis
por: Lim, Sian Yik, et al.
Publicado: (2017)